Figure 4From: Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancerThe median intracranial lesion local control time of CRT group had not yet been reached, and that of RT group was 11Â months. The 1- and 2-year intracranial lesion local control rates were 75.9% and 65.2% for CRT group and 41.6% and 31.2% for RT group.Back to article page